Journals / Experimental Biomedical Research / 2019 / Cilt: 2 - Sayı: 4

Five-year experience of neurosyphilis cases in a tertiary care hospital in Turkey

Pages
158–162
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that of the 61 patients who were examined for differential diagnosis of syphilis, 36 (%59) of them were referred from neurology clinic, 15 (25%) from infectious diseases clinic, 7 (12%) from dermatology clinic and 3 (4%) from gynecology clinic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate retrospectively the cases of syphilis who applied to different clinics of our hospital in the last 5 years and to emphasize the importance of admission screening tests in the diagnosis of neurosyphilis which is a rare but serious form of syphilis.
📊
Key Findings & Data:Methods: Sixty-one patients who admitted to different clinics of our hospital between 2013 and 2017 with different clinical manifestations and positive Venereal Disease Research Laboratory (VDRL) and Treponema pallidum microhemagglutination assay (TPHA) tests were recorded and analyzed retrospectively.
💡
Conclusion & Impact:It was found that of the 61 patients who were examined for differential diagnosis of syphilis, 36 (%59) of them were referred from neurology clinic, 15 (25%) from infectious diseases clinic, 7 (12%) from dermatology clinic and 3 (4%) from gynecology clinic.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

Aim: To evaluate retrospectively the cases of syphilis who applied to different clinics of our hospital in the last 5 years and to emphasize the importance of admission screening tests in the diagnosis of neurosyphilis which is a rare but serious form of syphilis. Methods: Sixty-one patients who admitted to different clinics of our hospital between 2013 and 2017 with different clinical manifestations and positive Venereal Disease Research Laboratory (VDRL) and Treponema pallidum microhemagglutination assay (TPHA) tests were recorded and analyzed retrospectively. Results: Both VDRL and TPHA tests were positive in 44 males with a mean age of 57.4 ± 18.4 years and 17 females with a mean age of 65.3 ± 19.1 years. It was found that of the 61 patients who were examined for differential diagnosis of syphilis, 36 (%59) of them were referred from neurology clinic, 15 (25%) from infectious diseases clinic, 7 (12%) from dermatology clinic and 3 (4%) from gynecology clinic. The clinical presentation was venereal chancre in 15 cases, asymptomatic ischemic brain lesions in 17 cases, acute ischemic stroke in 13 cases, movement disorder in three cases, tabes dorsalis in two cases, tendinitis-arthritis in eight cases, Amyotrophic lateral sclerosis (ALS) in one case, Deep venous thrombosis (DVT) in one case, and pulmonary nodule in one case. Conclusions: In conclusion, syphilis is often overlooked in the differential diagnosis in patient with neurological findings. Since neurosyphilis is an easily treatable disease, it should be considered in the differential diagnosis of patients presenting with neurological findings.

🔖

Cite This Article

OGUN, M. N., SIRMATEL, F. (2019). Five-year experience of neurosyphilis cases in a tertiary care hospital in Turkey. Experimental Biomedical Research, Cilt: 2 - Sayı: 4, 158–162. https://ajindex.com/articles/160324

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rotman L, Luo X, Thompson A, Mackesy- Amiti ME, Young LR, Young JD. Risk of neurosyphilis in HIV-infected persons with syphilis lacking signs or symptoms of central nervous system infection. HIV Med. 2019;20(1):27-32
  2. Akinci E, Oncu F, Topcular B. Neurosyphilis in Psychiatric Settings: Three case reports. Turk Psikiyatri Derg. 2017;28(1):61-66
  3. Schmidt RP. Neurosyphilis: In Joynt RJ (editor). Clinical Neurology Vol. 2 Revised edition. Philadelphia: Lippincott Williams & Wilkins, 1992, 1-23
  4. Berger JR. Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. A prospective study. Arch Neurol. 1991;48(7):700-2
  5. Fitzgerald F. The great imitator, syphilis. West J Med. 1981;134(5):424-32
  6. Wöhrl S, Geusau A. Neurosyphilis is unlikely in patients with late latent syphilis and a negative blood VDRL-test. Acta Derm Venereol. 2006;86(4):335-39
  7. Davis AP, Stern J, Tantalo L, Sahi S, Holte S, Dunaway S, et al. How Well Do Neurologic Symptoms Identify Individuals With Neurosyphilis? Clin Infect Dis. 2018;66(3):363-67
  8. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 1995;8(1):1-21
  9. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med. 1991;114(12):1005-9
  10. Brown ST, Zaidi A, Larsen SA, Reynolds GH. Serological response to syphilis treatment. A new analysis of old data. JAMA. 1985;253(9):1296-99
  11. Muga R, Roca J, Tor J, Pigem C, Rodriguez R, Egea JM, et al. Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs. Int J STD AIDS. 1997;8(4):225-28
  12. Young H. Syphilis: new diagnostic directions. Int J STD AIDS. 1992;3(6):391- 413
  13. Mitsonis CH, Kararizou E, Dimopoulos N, Triantafyllou N, Kapaki E, Mitropoulos P, et al. Incidence and clinical presentation of neurosyphilis: a retrospective study of 81 cases. Int J Neurosci. 2008;118(9):1251-57
  14. Nakashima AK, Rolfs RT, Flock ML, Kilmarx P, Greenspan JR. Epidemiology of syphilis in the United States, 1941--1993. Sex Transm Dis. 1996;23(1):16-23
  15. Lukehart SA, Hook EW 3rd, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med. 1988;109(11):855-62
  16. Hagihara M, Yamagishi Y, Kato H, Shibata Y, Shiota A, Sakanashi D, et al. Frequency of Treponema pallidum